Stock Track | Pacira Pharmaceuticals Plummets 13.37% Intraday After Reporting Preliminary FY25 Revenue Results

Stock Track
01/10

Pacira Pharmaceuticals (PCRX) saw its stock price plummet by 13.37% during intraday trading on Friday, as investors reacted to the company's preliminary FY25 revenue results.

The sharp decline followed the release of the preliminary financial results, which likely fell short of market expectations. The healthcare sector was already under pressure, with health care stocks dipping by 0.5% on Friday, adding to the downward momentum for PCRX.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10